Guillena, Concepcion M.

HRN: 09-88-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/07/2023
10/13/2023
IV
500mg
Q24
Complicated UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: